Envestnet Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-42,115
Closed -$336K 3268
2020
Q3
$336K Buy
+42,115
New +$336K ﹤0.01% 2684